XBH-52

N/A

Report date: 2024/04/24 14:11:53

Base Information

Drug NameXBH-52
Drug Alias NameXBH-52XBH52
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionKiller cell immunoglobulin-like receptor 3DL2 modulators
TargetsKiller cell immunoglobulin-like receptor 3DL2
Therapy Area/IndicationsSolid tumoursAutoimmune DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesChance Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesChance Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsSolid tumoursAutoimmune Diseases
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A